Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC for Pain and Function in Late-Stage Solid Tumors
NCT03057314Phase 1Terminated
- Sponsor
- Amorphical
- Start
- Jun 2017
- Primary completion
- Dec 2019
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of amorphous calcium carbonate in solid tumor, sponsored by Amorphical. Primary endpoint: Pain Visual Analog Score at Week 11. Started Jun 2017; status: terminated.
02
Drugs
amorphous calcium carbonate
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03057314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057314.